Home Industries Market Insights About Us Publisher Contact us

Global Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Region: Trend Forecast and Growth Opportunity

Published Date : 30-Jul-2021

Report Id : HNY198727

Pages : 160

Region: Worldwide

Global organ-on-chip market will reach $420.6 million by 2030, growing by 33.5% annually over 2020-2030 owing to the rising use of organ-on-a-chip (OOC) in early detection of drug toxicity, increasing demand for personalized medicine, the emergence of OOC as an alternative to animal testing, the significant increase in research funding and venture capital investments.
Highlighted with 82 tables and 83 figures, this 160-page report “Global Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global organ-on-chip market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global organ-on-chip market in every aspect of the classification from perspectives of Offering, Organ Type, Material, Application, End User, and Region.
Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Chips
• Service
Based on Organ Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Liver-on-a-Chip
• Heart-on-a-Chip
• Lung-on-a-Chip
• Kidney-on-a-Chip
• Brain-on-a-Chip
• Skin-on-a-Chip
• Vessels-on-a-Chip
• Other Organ Types
Based on Material, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Polymers
• Glass
• Silicon
Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Drug Discovery
• Toxicology Research
• Other Applications
Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Cosmetics Industry
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Organ Type, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
AxoSim Inc.
BiomimX SRL
Cherry Biotech
CN Bio Innovations, Ltd.
Emulate Inc.
Hurel Corporation
InSphero AG
Kirkstall, Ltd.
MIMETAS BV
Nortis Inc.
Organovo, Inc.
SynVivo, Inc.
Tara Biosystems Inc.
TissUse GmbH
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter’s Fiver Forces Analysis 37
3 Segmentation of Global Market by Offering 41
3.1 Market Overview by Offering 41
3.2 Chips 43
3.3 Service 44
4 Segmentation of Global Market by Organ Type 45
4.1 Market Overview by Organ Type 45
4.2 Liver-on-a-Chip 47
4.3 Heart-on-a-Chip 48
4.4 Lung-on-a-Chip 49
4.5 Kidney-on-a-Chip 50
4.6 Brain-on-a-Chip 51
4.7 Skin-on-a-Chip 52
4.8 Vessels-on-a-Chip 53
4.9 Other Organ Types 54
5 Segmentation of Global Market by Material 55
5.1 Market Overview by Material 55
5.2 Polymers 57
5.3 Glass 58
5.4 Silicon 59
6 Segmentation of Global Market by Application 60
6.1 Market Overview by Application 60
6.2 Drug Discovery 62
6.3 Toxicology Research 63
6.4 Other Applications 64
7 Segmentation of Global Market by End User 65
7.1 Market Overview by End User 65
7.2 Pharmaceutical and Biotechnology Companies 67
7.3 Academic and Research Institutes 68
7.4 Cosmetics Industry 69
7.5 Other End Users 70
8 Segmentation of Global Market by Region 71
8.1 Geographic Market Overview 2019-2030 71
8.2 North America Market 2019-2030 by Country 75
8.2.1 Overview of North America Market 75
8.2.2 U.S. 79
8.2.3 Canada 82
8.2.4 Mexico 84
8.3 European Market 2019-2030 by Country 86
8.3.1 Overview of European Market 86
8.3.2 Germany 90
8.3.3 U.K. 92
8.3.4 France 94
8.3.5 Spain 96
8.3.6 Italy 98
8.3.7 Russia 100
8.3.8 Rest of European Market 102
8.4 Asia-Pacific Market 2019-2030 by Country 104
8.4.1 Overview of Asia-Pacific Market 104
8.4.2 Japan 108
8.4.3 China 111
8.4.4 Australia 113
8.4.5 India 115
8.4.6 South Korea 117
8.4.7 Rest of APAC Region 119
8.5 South America Market 2019-2030 by Country 121
8.5.1 Argentina 124
8.5.2 Brazil 126
8.5.3 Chile 128
8.5.4 Rest of South America Market 130
8.6 MEA Market 2019-2030 by Country 131
8.6.1 UAE 134
8.6.2 Saudi Arabia 136
8.6.3 South Africa 138
8.6.4 Other National Markets 140
9 Competitive Landscape 141
9.1 Overview of Key Vendors 141
9.2 New Product Launch, Partnership, Investment, and M&A 144
9.3 Company Profiles 145
AxoSim Inc. 145
BiomimX SRL 147
Cherry Biotech 148
CN Bio Innovations, Ltd. 149
Emulate Inc. 150
Hurel Corporation 151
InSphero AG 152
Kirkstall, Ltd. 153
MIMETAS BV 154
Nortis Inc. 155
Organovo, Inc. 156
SynVivo, Inc. 157
Tara Biosystems Inc. 158
TissUse GmbH 159
RELATED REPORTS 160
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17
Figure 4. Global Organ-on-Chip Market, 2019-2030, $ mn 20
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of Global Organ-on-Chip Market 25
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 28
Figure 9. Primary Restraints and Impact Factors of Global Organ-on-Chip Market 30
Figure 10. Investment Opportunity Analysis 34
Figure 11. Porter’s Fiver Forces Analysis of Global Organ-on-Chip Market 37
Figure 12. Breakdown of Global Organ-on-Chip Market by Offering, 2019-2030, % of Revenue 42
Figure 13. Global Addressable Market Cap in 2021-2030 by Offering, Value ($ mn) and Share (%) 42
Figure 14. Global Organ-on-Chip Market: Chips, 2019-2030, $ mn 43
Figure 15. Global Organ-on-Chip Market: Service, 2019-2030, $ mn 44
Figure 16. Breakdown of Global Organ-on-Chip Market by Organ Type, 2019-2030, % of Sales Revenue 46
Figure 17. Global Addressable Market Cap in 2021-2030 by Organ Type, Value ($ mn) and Share (%) 46
Figure 18. Global Organ-on-Chip Market: Liver-on-a-Chip, 2019-2030, $ mn 47
Figure 19. Global Organ-on-Chip Market: Heart-on-a-Chip, 2019-2030, $ mn 48
Figure 20. Global Organ-on-Chip Market: Lung-on-a-Chip, 2019-2030, $ mn 49
Figure 21. Global Organ-on-Chip Market: Kidney-on-a-Chip, 2019-2030, $ mn 50
Figure 22. Global Organ-on-Chip Market: Brain-on-a-Chip, 2019-2030, $ mn 51
Figure 23. Global Organ-on-Chip Market: Skin-on-a-Chip, 2019-2030, $ mn 52
Figure 24. Global Organ-on-Chip Market: Vessels-on-a-Chip, 2019-2030, $ mn 53
Figure 25. Global Organ-on-Chip Market: Other Organ Types, 2019-2030, $ mn 54
Figure 26. Breakdown of Global Organ-on-Chip Market by Material, 2019-2030, % of Sales Revenue 56
Figure 27. Global Addressable Market Cap in 2021-2030 by Material, Value ($ mn) and Share (%) 56
Figure 28. Global Organ-on-Chip Market: Polymers, 2019-2030, $ mn 57
Figure 29. Global Organ-on-Chip Market: Glass, 2019-2030, $ mn 58
Figure 30. Global Organ-on-Chip Market: Silicon, 2019-2030, $ mn 59
Figure 31. Breakdown of Global Organ-on-Chip Market by Application, 2019-2030, % of Revenue 61
Figure 32. Global Addressable Market Cap in 2021-2030 by Application, Value ($ mn) and Share (%) 61
Figure 33. Global Organ-on-Chip Market: Drug Discovery, 2019-2030, $ mn 62
Figure 34. Global Organ-on-Chip Market: Toxicology Research, 2019-2030, $ mn 63
Figure 35. Global Organ-on-Chip Market: Other Applications, 2019-2030, $ mn 64
Figure 36. Breakdown of Global Organ-on-Chip Market by End User, 2019-2030, % of Revenue 66
Figure 37. Global Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%) 66
Figure 38. Global Organ-on-Chip Market: Pharmaceutical and Biotechnology Companies, 2019-2030, $ mn 67
Figure 39. Global Organ-on-Chip Market: Academic and Research Institutes, 2019-2030, $ mn 68
Figure 40. Global Organ-on-Chip Market: Cosmetics Industry, 2019-2030, $ mn 69
Figure 41. Global Organ-on-Chip Market: Other End Users, 2019-2030, $ mn 70
Figure 42. Global Market Snapshot by Region 71
Figure 43. Geographic Spread of Worldwide Organ-on-Chip Market, 2019-2030, % of Sales Revenue 72
Figure 44. Global Addressable Market Cap in 2021-2030 by Region, Value ($ mn) and Share (%) 73
Figure 45. North American Organ-on-Chip Market, 2019-2030, $ mn 76
Figure 46. Breakdown of North America Organ-on-Chip Market by Country, 2019 and 2030F, % of Revenue 77
Figure 47. Contribution to North America 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 78
Figure 48. U.S. Organ-on-Chip Market, 2019-2030, $ mn 80
Figure 49. Canada Organ-on-Chip Market, 2019-2030, $ mn 82
Figure 50. Organ-on-Chip Market in Mexico, 2015-2030F, $ mn 84
Figure 51. European Organ-on-Chip Market, 2019-2030, $ mn 87
Figure 52. Breakdown of European Organ-on-Chip Market by Country, 2019 and 2030F, % of Revenue 88
Figure 53. Contribution to Europe 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 89
Figure 54. Organ-on-Chip Market in Germany, 2019-2030, $ mn 90
Figure 55. Organ-on-Chip Market in U.K., 2019-2030, $ mn 92
Figure 56. Organ-on-Chip Market in France, 2019-2030, $ mn 94
Figure 57. Organ-on-Chip Market in Spain, 2019-2030, $ mn 96
Figure 58. Organ-on-Chip Market in Italy, 2019-2030, $ mn 98
Figure 59. Organ-on-Chip Market in Russia, 2019-2030, $ mn 100
Figure 60. Organ-on-Chip Market in Rest of Europe, 2019-2030, $ mn 102
Figure 61. Asia-Pacific Organ-on-Chip Market, 2019-2030, $ mn 105
Figure 62. Breakdown of APAC Organ-on-Chip Market by Country, 2019 and 2030F, % of Revenue 105
Figure 63. Contribution to APAC 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 107
Figure 64. Organ-on-Chip Market in Japan, 2019-2030, $ mn 109
Figure 65. Organ-on-Chip Market in China, 2019-2030, $ mn 111
Figure 66. Organ-on-Chip Market in Australia, 2019-2030, $ mn 113
Figure 67. Organ-on-Chip Market in India, 2019-2030, $ mn 115
Figure 68. Organ-on-Chip Market in South Korea, 2019-2030, $ mn 117
Figure 69. Organ-on-Chip Market in Rest of APAC, 2019-2030, $ mn 119
Figure 70. South America Organ-on-Chip Market, 2019-2030, $ mn 122
Figure 71. Breakdown of South America Organ-on-Chip Market by Country, 2019 and 2030F, % of Revenue 122
Figure 72. Contribution to South America 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 123
Figure 73. Organ-on-Chip Market in Argentina, 2019-2030, $ mn 124
Figure 74. Organ-on-Chip Market in Brazil, 2019-2030, $ mn 126
Figure 75. Organ-on-Chip Market in Chile, 2019-2030, $ mn 128
Figure 76. Organ-on-Chip Market in Rest of South America, 2019-2030, $ mn 130
Figure 77. Organ-on-Chip Market in Middle East and Africa (MEA), 2019-2030, $ mn 132
Figure 78. Breakdown of MEA Organ-on-Chip Market by Country, 2019 and 2030F, % of Revenue 132
Figure 79. Contribution to MEA 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 133
Figure 80. Organ-on-Chip Market in UAE, 2019-2030, $ mn 134
Figure 81. Organ-on-Chip Market in Saudi Arabia, 2019-2030, $ mn 136
Figure 82. Organ-on-Chip Market in South Africa, 2019-2030, $ mn 138
Figure 83. Growth Stage of Global Organ-on-Chip Industry over the Forecast Period 141

Request For Discount

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any), so we can get back to you with a solution

Buy Now

Single User

US$ 3300

Multi User

US$ 4600

Corporate User

US$ 5900

Related Reports

Global Organ-on-Chip Market 2020-2030 by Offering ...

RD Code : HNY198727